The impact of video-based cardiac rehabilitation education in patients with cardiovascular implantable electronic Devices(CIEDs)- a randomized controlled trial
NCT ID NCT06503445
First seen Sep 09, 2026 ยท Last updated Sep 09, 2026
Summary
Cardiac rehabilitation has the beneficial effects of secondary prevention and social psychological and physical health status in patients with cardiovascular diseases. International and clinical guidelines currently recommend exercise training and rehabilitation for heart failure patients, which can effectively improve mortality and prognosis. However, few of these recommendations have specific recommendations for patients with cardiac implantable electronic devices. Currently the recommendations of cardiac rehabilitation include patients with coronary heart disease (acute coronary heart disease, any coronary revascularization, stable coronary disease or unstable angina), patients with heart failure, after cardiac surgery, and patients with high cardiovascular risk. Many of these patients may be implanted with cardiac implantable electronic devices. In 2011, 938 pacemakers, 140 cardiac resynchronization therapy and 149 implantable cardioverter defibrillators were implanted per million inhabitants in Europe. Therefore, among the groups with cardiac implantable electronic devices, cardiac rehabilitation plays a certain role. The purpose of this study is to evaluate whether video-based cardiac rehabilitation health education for patients with cardiac implantable electronic devices has significantly improved physical activity. This study is designed as a prospective, single center, double-blind, randomized controlled trial. Divided into an experimental group and a control group at a ratio of 1:1. The experimental group with cardiac implantable electronic devices will receive cardiac rehabilitation health education video intervention, and the control group will receive only health education. We aim to recruit 45 participants per group with a total of 90 participants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
85 people
The number who actually took part.
- Started
-
Mar 2021
- Finished
-
Jul 2022
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
20 to 100 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age between 20-100 years old * Patients with cardiovascular implantable electronic devices(CIEDs) * CIEDs were implanted for more than 30 days without complications Exclusion Criteria: * cannot sign informed consent * cannot return for follow-up visits current or scheduled enrollment in other conflicting studies * concomitant disease (e.g., terminal cancer) or other medical condition likely to result in death within 6 months * patients with bed-ridden status could not perform home-based tele-rehabilitation * pregnancy
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Arrhythmia are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Taiwan University Hospital Hsin-Chu Branch
Hsinchu, 300, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Evaluation of the factors associated with bradtycardia following pulmonary vein isolation using pulsed field ablation
- Effect of the use of dapagliflozin in diuresis, natriuresis and in ultrafiltration and peritoneal elimination of sodium, in patients with refractory heart failure
- Can a 10-Week coaching program ease the toll on heart failure caregivers?
- Can a 10-Second chest scan reveal hidden heart clues?
- Which pacing target keeps the heart stronger? a trial aims to find out
- Can AI help nurses guide At-Risk seniors to better care and lower costs?